MEASUREMENT OF TUMOR GRADE AND RECEPTOR STATUS WITH RAMAN SPECTROSCOPY

$19,023P41FY2009RRNIH

Massachusetts Institute Of Technology, Cambridge MA

Investigators

Linked publications & trials

Paper 25688542 Paper 24065823 Paper 23880606 Paper 23843090 Paper 23485973 Paper 23267090 Paper 23231902 Paper 22887773 Paper 22828327 Paper 22820310 Paper 22815240 Paper 22746329 Paper 22559667 Paper 22463035 Paper 22393405 Paper 22324826 Paper 22303465 Paper 22292496 Paper 22274427 Paper 22125761 Paper 22099648 Paper 22025985 Paper 21991542 Paper 21895336 Paper 21811316 Paper 21797607 Paper 21728589 Paper 21699368 Paper 21698115 Paper 21509482 Paper 21478949 Paper 21412464 Paper 21288042 Paper 21280900 Paper 21280898 Paper 21280896 Paper 21280892 Paper 21280891 Paper 21263482 Paper 21193196 Paper 21113234 Paper 21050004 Paper 20729327 Paper 20634833 Paper 20575513 Paper 20482016 Paper 20459219 Paper 20372622 Paper 20351261 Paper 20080583 Paper 20055430 Paper 19999369 Paper 19997187 Paper 19953156 Paper 19895125 Paper 19803506 Paper 19725732 Paper 19717442 Paper 19654630 Paper 19645423 Paper 19550464 Paper 19413337 Paper 19405760 Paper 19405647 Paper 19392307 Paper 19208947 Paper 19129896 Paper 19123680 Paper 18825263 Paper 18825262 Paper 18798684 Paper 18794935 Paper 18772382 Paper 18711512 Paper 18711511 Paper 18628809 Paper 18562484 Paper 18465975 Paper 18387320 Paper 18197229 Paper 18163828 Paper 18163733 Paper 18087529 Paper 17930687 Paper 17694065 Paper 17546192 Paper 17356628 Paper 17339945 Paper 17283991 Paper 17194145 Paper 17041654 Paper 17026078 Paper 16965126 Paper 16936883 Paper 16864788 Paper 16851745 Paper 16675721 Paper 16674182 Paper 16674178 Paper 16544620

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The diagnostic potential of Raman spectroscopy to detect breast cancer has been demonstrated in both in vitro, ex vivo and in vivo studies. The next step towards developing a comprehensive algorithm is to explore the feasibility of Raman spectroscopy as a real-time method for prediction of prognosis and ultimately clinical outcome. We will collect Raman spectra from breast cancer lesions and correlate spectral features with tumor grade and receptor status.

View original record on NIH RePORTER →